Back
Janus Henderson Small Cap Growth Alpha ETF Vs. Blueprint Medicines Industry Stock Comparison
Sell
46
JSML
Janus Henderson Small Cap Growth Alpha ETF
Last Price:
$67.53
Seasonality Move:
-0.6%
Buy
53
BPMC
Blueprint Medicines
Last Price:
$129.46
Seasonality Move:
1.87%
Sell
46
Janus Henderson Small Cap Growth Alpha ETF (JSML)
is a Sell
Is Janus Henderson Small Cap Growth Alpha ETF a Buy, Sell or Hold?
-
The current Janus Henderson Small Cap Growth Alpha ETF [JSML] share price is $67.17. The Score for JSML is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
JSML is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Blueprint Medicines (BPMC)
is a Buy
Is Blueprint Medicines a Buy, Sell or Hold?
-
The current Blueprint Medicines [BPMC] share price is $129.46. The Score for BPMC is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
BPMC is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
JSML Stock Price Chart
What is Janus Henderson Small Cap Growth Alpha ETF's stock price today?
-
The Janus Henderson Small Cap Growth Alpha ETF share price today is $67.17Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and JSML is experiencing selling pressure, which indicates risk of future bearish movement.
BPMC Stock Price Chart
What is Blueprint Medicines's stock price today?
-
The Blueprint Medicines share price today is $129.46Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.
JSML Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 18.58 | Buy |
Relative Strength Index (14 RSI): | 50.81 | Buy |
Chaikin Money Flow: | -21705 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.19 - 68.17) | Sell |
Bollinger Bands (100): | (59.11 - 66.75) | Buy |
BPMC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.49 | Buy |
Relative Strength Index (14 RSI): | 76.66 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (128.07 - 129.15) | Buy |
Bollinger Bands (100): | (85.79 - 122.45) | Buy |
JSML Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.74 | Sell |
20-day SMA: | 67.55 | Sell |
50-day SMA: | 66.2 | Buy |
200-day SMA: | 65.44 | Buy |
8-day EMA: | 62.17 | Buy |
20-day EMA: | 42.85 | Buy |
50-day EMA: | 22.36 | Buy |
200-day EMA: | 6.46 | Buy |
BPMC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 129.38 | Buy |
20-day SMA: | 128.73 | Buy |
50-day SMA: | 119.37 | Buy |
200-day SMA: | 99.85 | Buy |
8-day EMA: | 129.26 | Buy |
20-day EMA: | 127.9 | Buy |
50-day EMA: | 120.09 | Buy |
200-day EMA: | 103.72 | Buy |
Janus Henderson Small Cap Growth Alpha ETF Earnings Growth & JSML Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Blueprint Medicines Earnings Growth & BPMC Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.52 per share, an increase next quarter of $0.48 per share, an increase this year of $0.60 per share, and an increase next year of $1.59 per share.
Janus Henderson Small Cap Growth Alpha ETF Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Blueprint Medicines Technical Analysis
Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |